Return to search

Sistema melatonérgico como alvo do peptídeo β-amiloide / The melatonergic system as a target of amyloid-β peptide

A doença de Alzheimer (AD) é a doença neurodegenerativa relacionada ao envelhecimento mais frequente no mundo. Uma das características moleculares de AD é a produção exacerbada de peptídeos beta-amiloide (Aβ), principalmente dos fragmentos de 40 e 42 aminoácidos (Aβ1-40 e Aβ1-42). Aβ induz respostas neuroinflamatórias e alterações moleculares relacionadas à perda sináptica e morte neuronal. Diversos relatos mostram que pacientes de AD apresentam redução na concentração plasmática de melatonina, hormônio produzido pela glândula pineal e também alteração na expressão dos receptores de melatonina, mas os mecanismos envolvidos ainda não são conhecidos. De acordo com o conceito do eixo imunepineal, agentes inflamatórios são capazes de atuar diretamente sobre a glândula pineal e inibir a síntese de melatonina. No presente estudo investigamos, portanto, se o peptídeo Aβ atua diretamente sobre o sistema melatonérgico, modulando a síntese de melatonina ou a função de seus receptores. Pineais em cultura tratadas com Aβ 1-40 ou Aβ 1-42 apresentaram redução na produção de melatonina. Aβ 1-40 ativou a via do fator de transcrição NF-κB na pineal, resultando em aumento da transcrição de diversos genes inflamatórios, como interleucinas e quimiocinas, e inibição da expressão da enzima arilalquilamina N-acetiltransferase, essencial à síntese de melatonina. Em células HEK293 expressando estavelmente receptores MT1 ou MT2 recombinantes, a ativação da via ERK1/2 pela melatonina foi inibida tanto por Aβ 1-40 quanto por Aβ 1-42. O mesmo efeito inibitório foi observado em células endoteliais primárias que expressam MT1 e MT2 constitutivamente. O presente trabalho mostra que a síntese de melatonina pela pineal e a função dos receptores de melatonina são diretamente regulados por Aβ, o que amplia nossos conhecimentos a respeito dos efeitos prejudiciais de Aβ. Considerando que a melatonina tem propriedades neuroprotetora e antioxidante, a disfunção do sistema melatonérgico pode contribuir para os processos neurodegenerativos que ocorrem na patologia de AD / Alzheimer\'s disease (AD) is the most common age-related neurodegenerative disorder worldwide. Excess of amyloid beta peptides (Aβ), composed mainly by 40 and 42 aminoacids-long fragments (Aβ 1-40 e Aβ 1-42) is a molecular hallmark in AD. Aβ-induced neuroinflammatory responses and molecular changes are related to synapse impairment and neuronal loss. It is well documented that AD patients show impaired melatonin synthesis, the pineal gland-derived hormone, and altered expression of melatonin receptors, but the underlying mechanisms remain unclear. According to the immune-pineal axis concept, inflammatory mediators act on the pineal gland, leading to inhibition of melatonin synthesis. Therefore, in the present study we sought to investigate whether Aβ? directly targets the melatonergic system, modulating melatonin synthesis and/or melatonin receptors function. Pineal glands cultured in the presence of Aβ 1-40 or Aβ 1-42 showed reduced melatonin production. Aβ 1-40 activated the nuclear factor kappa B (NF-κ B) pathway in the pineal gland, leading to up-regulation of several inflammatory genes, as interleukins and chemokines, and inhibition of the arylalkylamine N-acetyltransferase enzyme expression, the key enzyme in melatonin synthesis. In HEK293 cells stably expressing recombinant melatonin MT1 or MT2 receptors melatonin-induced ERK1/2 activation was markedly impaired by Aβ 1-40 and Aβ 1-42. Similar results were obtained in primary culture of endothelial cells expressing melatonin receptors endogenously. The present study shows that melatonin synthesis and melatonin receptors function are directly impaired by Aβ, thus extending our understanding on the detrimental effects of Aβ. Because melatonin shows neuroprotective and antioxidant properties, impairment of the melatonergic system may contribute to the neurodegenerative processes that take place in AD. 1-42) is a molecular hallmark in AD. Aβ-induced neuroinflammatory responses and molecular changes are related to synapse impairment and neuronal loss. It is well documented that AD patients show impaired melatonin synthesis, the pineal gland-derived hormone, and altered expression of melatonin receptors, but the underlying mechanisms remain unclear. According to the immune-pineal axis concept, inflammatory mediators act on the pineal gland, leading to inhibition of melatonin synthesis. Therefore, in the present study we sought to investigate whether Aβ?directly targets the melatonergic system, modulating melatonin synthesis and/or melatonin receptors function. Pineal glands cultured in the presence of Aβ 1-40 or Aβ 1-42 showed reduced melatonin production. Aβ 1-40 activated the nuclear factor kappa B (NF-&kappa B) pathway in the pineal gland, leading to up-regulation of several inflammatory genes, as interleukins and chemokines, and inhibition of the arylalkylamine N-acetyltransferase enzyme expression, the key enzyme in melatonin synthesis. In HEK293 cells stably expressing recombinant melatonin MT1 or MT2 receptors melatonin-induced ERK1/2 activation was markedly impaired by Aβ 1-40 and Aβ 1-42. Similar results were obtained in primary culture of endothelial cells expressing melatonin receptors endogenously. The present study shows that melatonin synthesis and melatonin receptors function are directly impaired by Aβ, thus extending our understanding on the detrimental effects of Aβ. Because melatonin shows neuroprotective and antioxidant properties, impairment of the melatonergic system may contribute to the neurodegenerative processes that take place in AD

Identiferoai:union.ndltd.org:IBICT/oai:teses.usp.br:tde-29092014-083625
Date02 July 2014
CreatorsErika Cecon
ContributorsRegina Pekelmann Markus, Ana Campa, Rosely Oliveira Godinho, Vilma Regina Martins, Cristoforo Scavone
PublisherUniversidade de São Paulo, Fisiologia Geral, USP, BR
Source SetsIBICT Brazilian ETDs
LanguagePortuguese
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/doctoralThesis
Sourcereponame:Biblioteca Digital de Teses e Dissertações da USP, instname:Universidade de São Paulo, instacron:USP
Rightsinfo:eu-repo/semantics/openAccess

Page generated in 0.0068 seconds